Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy

Pancreas. 2017 May/Jun;46(5):589-594. doi: 10.1097/MPA.0000000000000825.

Authors

Robert T Jensen¹, Jeffrey A Norton

Affiliation

¹ From the *Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD; and the †Department of Surgery, Stanford University School of Medicine, Stanford, CA.

No abstract available

Publication types

Research Support, N.I.H., Intramural

MeSH terms

Humans
Multiple Endocrine Neoplasia Type 1 / diagnosis
Multiple Endocrine Neoplasia Type 1 / genetics
Multiple Endocrine Neoplasia Type 1 / therapy*
Neuroendocrine Tumors / diagnosis
Neuroendocrine Tumors / genetics
Neuroendocrine Tumors / therapy*
Outcome Assessment, Health Care
Pancreatic Neoplasms / diagnosis
Pancreatic Neoplasms / genetics
Pancreatic Neoplasms / therapy*

Grants and funding